Non-alcoholic fatty liver disease: Role of PNPLA3 and its association with environmental chemicals
Archives of Clinical Toxicology · 2024
DOI: 10.46439/toxicology.6.029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Clinical Toxicology, 2024. Verfasst von Shakil A Saghir und 6 weiteren Autor:innen. Beteiligte Einrichtung: ToxInternational Inc., Hilliard, OH, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Globally, non-alcoholic fatty liver disease (NAFLD) is on the rise with 30-32%, 27-33%, 35-48%, 36%, 9-20%, and 36-38% prevalence in Asia, Europe, North America, South America, Africa, and Australia, respectively. Approximately, 5-10% of NAFLD proceeds to hepatitis called non-alcoholic steatohepatitis (NASH). NASH often progresses to liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Precise mechanism(s) for the development of HCC is not fully understood in NAFLD and NASH patients. Higher insulin levels in type 2 diabetes (T2D) can result in lipolysis of adipose tissue activating lipid synthesizing enzymes such as fatty acid synthase and stearoyl-CoA desaturase-1, resulting in lipid accumulation in liver. Higher levels of glucose in T2D patients activate carbohydrate response element binding protein and insulin which increases the level of active sterol regulatory element binding protein. These lipogenic transcription factors activate patatin-like phospholipase domain-containing protein-3 (PNPLA3) from their response elements in the promoter. Endocrine disrupting chemicals (EDCs) and persistent organic pollutants (POPs) are implicated in T2D development and NAFLD. The emerging association between POPs, including insecticides, fungicides, herbicides, and diabetes has been noted. However, their connection with NAFLD remains less evident. Here, we reviewed association of POPs, especially EDCs, and role of PNPLA3 in the development of NAFLD and NASH. We also reviewed the role of single nucleotide polymorphisms of PNPLA3’s association with NAFLD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ToxInternational Inc., Hilliard, OH, USA.
- Department of Biological & Biomedical Sciences, Aga Khan Univ, Karachi, Pakistan.
- Institute of Environmental Science and Meteorology, University of the Philippines-Diliman, Quezon City 1101 Philippines.
- Division of Hematology and Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
- Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Health Professions Division, Nova Southeastern University, Fort Lauderdale, FL, USA.
Förderung
- NEI NIH HHS
- NCI NIH HHS
Zitieren
APA
Saghir, S. A., Abbas, A., Alfuraih, S., Sharma, A., Latimer, J., Omidi, Y., & Ansari, R. (2024). Non-alcoholic fatty liver disease: Role of PNPLA3 and its association with environmental chemicals. Archives of Clinical Toxicology. https://doi.org/10.46439/toxicology.6.029
Vancouver
Saghir SA, Abbas A, Alfuraih S, Sharma A, Latimer J, Omidi Y, et al. Non-alcoholic fatty liver disease: Role of PNPLA3 and its association with environmental chemicals. Archives of Clinical Toxicology. 2024. doi:10.46439/toxicology.6.029
BibTeX
@article{Saghir2024,
author = {Saghir, Shakil A and Abbas, Ata and Alfuraih, Saleh and Sharma, Ajay and Latimer, Jean and Omidi, Yadollah and Ansari, Rais},
title = {Non-alcoholic fatty liver disease: Role of PNPLA3 and its association with environmental chemicals},
journal = {Archives of Clinical Toxicology},
year = {2024},
doi = {10.46439/toxicology.6.029}
}
EUVIMED